www.abbvie.co.uk
Open in
urlscan Pro
2606:4700::6812:3e5
Public Scan
Submitted URL: http://www.abbvie.co.uk/
Effective URL: https://www.abbvie.co.uk/
Submission: On January 22 via api from US — Scanned from DE
Effective URL: https://www.abbvie.co.uk/
Submission: On January 22 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMGET /search.html
<form method="get" class="cmp-searchinputfield__form" action="/search.html">
<div class="cmp-searchinputfield__form-group">
<div>
<input type="search" placeholder="Type in your search and press enter..." data-mobile-placeholder="Type in your search..." data-desktop-placeholder="Type in your search and press enter..." name="q" class="cmp-searchinputfield__input"
maxlength="100"> <input type="hidden" name="_charset_" value="UTF-8">
</div>
</div>
</form>
GET /search.html
<form class="cmp-searchinputfield__mobile-form" method="get" action="/search.html">
<div class="cmp-searchinputfield__mobile-form-group">
<div>
<input aria-label="Search" type="search" placeholder="Type in your search..." data-mobile-placeholder="Type in your search..." data-desktop-placeholder="Type in your search and press enter..." name="q" maxlength="100"
class="cmp-searchinputfield__mobile-input">
<input type="hidden" name="_charset_" value="UTF-8">
</div>
</div>
</form>
Text Content
Skip to main content United Kingdom • EN * Stories * Media * AbbVie Global opens in a new window Menu * Our Company * Explore Our Company * Strategy * At A Glance * Recognition * Policies & Disclosures * Ethics & Compliance * Our Science * Explore Our Science * Therapeutic Focus Areas * Explore Therapeutic Focus Areas * Immunology * Oncology * Neuroscience * Virology * Technologies & Platforms * COVID-19 R&D * 2022 AbbVie UK Golden Ticket * Societal Impact * Explore Societal Impact * For the Well-Being of Patients * Explore For the Well-Being of Patients * Shared Decision Making * Accessing the Future of Better Care, Quicker * Bridging the Gap * For the Strength of Our Communities * Explore For the Strength of Our Communities * Grants, Donations & Charitable Contributions * Employee Giving * For the Resilience of Our Business * Explore For the Resilience of Our Business * Upholding the Highest Quality * Sustainable Supply Chain * Careers * Explore Careers * Working at AbbVie * Roles * Explore Roles * Corporate * Research & Development * Operations * Commercial * AbbVie Around the World * Equity Equality, Diversity & Inclusion * Stories * Media * AbbVie Global opens in a new window Search Close Search Type in your search... Toggle Ancillary Navigation PROMOTING GREAT IDEAS FOR A SUSTAINABLE NHS The NHS is precious. Following the impact of COVID19 we’re working to support and build a sustainable NHS. Through partnerships, innovative medicines and shared decision making we want to build a sustainable healthcare ecosystem, to bring patients and clinicians the future of better care, quicker. Learn More CONTRIBUTE TO COMMUNITIES GRANTS, DONATIONS & CHARITABLE CONTRIBUTIONS IMPROVING HEALTHCARE OUTCOMES SHARED DECISION MAKING CAREERS OUR COMMITTMENT TO EQUALITY, EQUITY, DIVERSITY & INCLUSION MAKING POSSIBILITIES REAL Our employees work every day to discover and address many of the world's most pressing health challenges. Search Careers 50,000+ people treated by AbbVie medicines in the UK 16 academic, commercial and consortium efforts supported by AbbVie in the UK £60M million committed to Research and Development in the UK since 2018 1 of 3 2 of 3 3 of 3 Previous Next Pause Play 1. slide1 2. slide2 3. slide3 OUR COMPANY At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people's lives. See how we're improving healthcare on a global basis. Learn More $35 MILLION donated to support COVID19 relief efforts across the globe 5 global partnerships supporting research into the COVID19 pandemic 100 UK patients supported through the Early Access to Medicines scheme between 2017 and 2021 1 of 3 2 of 3 3 of 3 Previous Next Pause Play 1. slide1 2. slide2 3. slide3 INNOVATION Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients. Explore November 2022 UK-ABBV-220607 Return to top * Contact 1. Follow us on Twitter opens in a new window 2. Follow us on YouTube opens in a new window * Site Map * Privacy Policy * Terms of Use Cookie Settings Copyright © 2022 AbbVie Inc. North Chicago, Illinois, U.S.A. Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company. UK-ABBV-220119 × LEAVE THE UK SITE The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. YES I would like to continue to the site Continue NO I do not want to leave this site Stay × LEAVE THE UK SITE You are leaving to a site that is not controlled by AbbVie. The “accept” button below will take you out of AbbVie family of websites. Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience. The inclusion of any link does not imply endorsement of the linked site by AbbVie. YES I understand and would like to continue to the site Agree NO I do not want to continue to a third party site No